封面
市場調查報告書
商品編碼
1433570

造影超音波市場市場規模、佔有率、趨勢分析報告:按產品類型、最終用途、地區和細分市場預測,2024-2030 年

Contrast Enhanced Ultrasound Market Size, Share & Trends Analysis Report By Product, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

造影超音波市場成長與趨勢:

預計到 2030 年,全球造影超音波市場將達到 29.9 億美元。

根據Grand View Research, Inc.的最新報告,預計2024年至2030年複合年成長率為5.70%。心血管疾病、癌症和肝臟疾病等慢性病盛行率的上升、老年人口的增加以及超音波成像技術的不斷進步預計將推動預測期內超音波造影的成長,這是主要因素。與 CT 和 MRI 等其他造影方式相比,對比超音波的使用進一步推動了市場成長,因為其成本較低、攜帶且無電離輻射。

心血管疾病盛行率的上升推動了市場的成長。根據世界衛生組織 (WHO) 統計,心血管疾病每年導致約 1,790 萬人死亡,成為全球第一大死因。 2022年,被診斷出患有心血管疾病的人數預計將增加。因此,造影超音波(CEUS)在這些疾病的檢測和監測中發揮重要作用。 CEUS 使用造影顯影劑增強超音波影像,以更清晰地顯示心臟和血管。可用於診斷心臟瓣膜疾病、主動脈瘤、周邊動脈疾病等。

此外,CEUS是一種非侵入性且安全的成像方法,不使用電離輻射。這使其成為優於使用電離輻射的 CT 和 MRI 等其他顯像模式的首選。 2021年,發表在《美國心臟病學會雜誌》上的一項研究表明,與其他顯像模式相比,CEUS在檢測冠狀動脈疾病方面具有更高的診斷準確性。 CEUS以其許多優點,正成為心血管疾病診斷和治療中越來越重要的工具。

造影超音波市場報告亮點:

  • 按產品分類,2023年設備部門佔收益佔有率最大。這是由於與 CEUS 相容的超音波成像技術擁有最大的裝置量。
  • 由於 FDA核准其用於肝臟和兒童成像,預計顯影劑年成長率快速成長。
  • 按類型分類,非標靶細分市場在 2023 年佔據了最大的收益佔有率,因為大多數市售顯影劑都是非標靶的。
  • 由於腹痛、腹部/胸部創傷和心臟併發症等醫療狀況導致的緊急就診數量增加,醫院細分市場在 2023 年佔據了最大的市場佔有率。
  • 隨著初級和二級護理醫生透過使用超音波檢查設備實現經濟和患者照護效益,預計診所部門在預測期內將實現良好的複合年成長率。
  • 在亞太地區,由於 CT 和 MRI 等先進 CT/MRI顯像模式的獲取有限,以及中國和印度心血管疾病負擔的增加,該市場預計將以最快的複合年成長率成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章造影超音波市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 造影超音波市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章造影超音波市場:按產品估計和趨勢分析

  • 按產品分類的市場佔有率(2023/2030)
  • 細分儀表板
  • 按產品分類的全球造影超音波市場前景
  • 市場規模、預測與趨勢分析(2018-2030)

第5章造影超音波市場:按類型估計和趨勢分析

  • 按類型分類的市場佔有率(2023/2030)
  • 細分儀表板
  • 按類型分類的全球造影超音波市場展望
  • 市場規模、預測與趨勢分析(2018-2030)

第6章造影超音波市場:依最終用途分類的估計與趨勢分析

  • 依最終用途分類的市場佔有率(2023/2030)
  • 細分儀表板
  • 按最終用途分類的全球造影超音波市場前景
  • 市場規模、預測與趨勢分析(2018-2030)

第7章造影超音波市場:按地區估計和趨勢分析

  • 按地區分類的市場佔有率分析(2023/2030)
  • 按地區分類的市場儀表板
  • 按地區市場概述
  • 市場規模、預測與趨勢分析(2018-2030)
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Lantheus Medical Imaging, Inc.
    • GE Healthcare
    • Bracco Diagnostic
    • GE HealthCare
    • Siemens Healthcare GmbH
    • Koninklijke Philips NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product Code: GVR-4-68039-141-1

Contrast Enhanced Ultrasound Market Growth & Trends:

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030. It is projected to grow at a CAGR of 5.70% from 2024 - 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic disorders such as cardiovascular ailments, cancer, and liver disease, growing geriatric population, and increasing technological advancements in the ultrasound imaging technology are the major factors anticipated to boost the contrast-enhanced ultrasound market growth over the forecast period. Growth in the market is further propelled using contrast-enhanced ultrasound over other imaging modalities like CT and MRI has become more popular due to its lower cost, portability, and lack of ionizing radiation.

The rising prevalence of cardiovascular diseases fueling the market growth. According to the World Health Organization (WHO), an estimated 17.9 million deaths occur each year due to cardiovascular diseases, making it the leading cause of death globally. In 2022, it is expected that there will be an increase in the number of people diagnosed with cardiovascular diseases. This is where contrast-enhanced ultrasound (CEUS) can play a crucial role in helping to detect and monitor these conditions. CEUS uses a contrast agent that enhances the ultrasound image, allowing for better visualization of the heart and blood vessels. It can be used to diagnose conditions such as heart valve disease, aortic aneurysm, and peripheral artery disease.

Furthermore, CEUS is a non-invasive and safe imaging modality that does not use ionizing radiation. This makes it a preferred option over other imaging modalities like CT and MRI, which use ionizing radiation. In 2021, a study published in the Journal of the American College of Cardiology showed that CEUS had high diagnostic accuracy in detecting coronary artery disease compared to other imaging modalities. With its many benefits, CEUS is becoming an increasingly important tool in diagnosing and managing cardiovascular diseases.

Contrast Enhanced Ultrasound Market Report Highlights:

  • Based on product, the equipment segment held the largest revenue share in 2023. This can be attributed to the largest installed base of ultrasound imaging technology compatible with CEUS.
  • The contrast agents segment is expected to grow at the fastest CAGR of 6.32% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA.
  • Based on type, the non-targeted segment held the largest revenue share in 2023 as most of the commercially available contrast agents are non-targeted in nature.
  • The hospitals segment held the largest market share in 2023 owing to the increasing number of emergency visits with medical conditions such as abdominal pain, abdominal/thoracic trauma, and cardiac complications
  • The clinics segment is anticipated to witness lucrative CAGR over the forecast period owing to the realization of economic and patient care benefits with the adoption of sonography devices in practice among physicians at primary and secondary care
  • In Asia Pacific, the market is expected to grow at the fastest CAGR owing to the limited accessibility to advanced CT/MRI imaging modalities such as CT and MRI, and the growing burden of cardiovascular disorders in China and India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. End-use
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic disorders
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Extension of indications for use
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low stability of the contrast agents
      • 3.2.2.2. Procedural complexity
      • 3.2.2.3. Availability of alternatives
  • 3.3. Contrast Enhanced Ultrasound Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Contrast Enhanced Ultrasound Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Equipment
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Contrast Agents
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Contrast Enhanced Ultrasound Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Non-targeted
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Targeted
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Contrast Enhanced Ultrasound Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Contrast Enhanced Ultrasound Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Clinics
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Ambulatory Diagnostic Centers
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Lantheus Medical Imaging, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. GE Healthcare
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bracco Diagnostic
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE HealthCare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthcare GmbH
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Koninklijke Philips N.V.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CANON MEDICAL SYSTEMS CORPORATION
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 15 Europe contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 23 France contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 24 France contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 33 Denmark contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 36 Sweden contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 39 Norway contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 45 China contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 46 China contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 51 India contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 52 India contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Korea contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 61 Thailand contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 75 Mexico contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 76 Mexico Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Mexico market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Mexico Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Mexico contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Argentina contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 81 Argentina contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Argentina market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 Argentina Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Argentina contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 MEA contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 87 MEA contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 88 MEA contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 89 MEA contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 South Africa contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 91 South Africa contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 92 South Africa contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 UAE contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 97 UAE contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 98 UAE contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Kuwait contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 100 Kuwait contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 101 Kuwait contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Contrast enhanced ultrasound market: market outlook
  • Fig. 14 Contrast enhanced ultrasound market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Contrast enhanced ultrasound market driver impact
  • Fig. 20 Contrast enhanced ultrasound market restraint impact
  • Fig. 21 Contrast enhanced ultrasound market strategic initiatives analysis
  • Fig. 22 Contrast enhanced ultrasound market: Product movement analysis
  • Fig. 23 Contrast enhanced ultrasound market: Product outlook and key takeaways
  • Fig. 24 Equipment market estimates and forecast, 2018 - 2030
  • Fig. 25 Contrast agents estimates and forecast, 2018 - 2030
  • Fig. 26 Contrast enhanced ultrasound market: Type movement Analysis
  • Fig. 27 Contrast enhanced ultrasound market: Type outlook and key takeaways
  • Fig. 28 Non-targeted market estimates and forecasts, 2018 - 2030
  • Fig. 29 Targeted market estimates and forecasts,2018 - 2030
  • Fig. 30 Contrast enhanced ultrasound market: end-use movement analysis
  • Fig. 31 Contrast enhanced ultrasound market: end-use outlook and key takeaways
  • Fig. 32 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 33 Clinics market estimates and forecasts,2018 - 2030
  • Fig. 34 Ambulatory diagnostic centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global contrast enhanced ultrasound market: Regional movement analysis
  • Fig. 36 Global contrast enhanced ultrasound market: Regional outlook and key takeaways
  • Fig. 37 Global contrast enhanced ultrasound market share and leading players
  • Fig. 38 North America market share and leading players
  • Fig. 39 Europe market share and leading players
  • Fig. 40 Asia Pacific market share and leading players
  • Fig. 41 Latin America market share and leading players
  • Fig. 42 Middle East & Africa market share and leading players
  • Fig. 43 North America: SWOT
  • Fig. 44 Europe SWOT
  • Fig. 45 Asia Pacific SWOT
  • Fig. 46 Latin America SWOT
  • Fig. 47 MEA SWOT
  • Fig. 48 North America
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 U.S.
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Canada
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 54 Europe
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 56 UK
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany
  • Fig. 59 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 60 France
  • Fig. 61 France market estimates and forecasts, 2018 - 2030
  • Fig. 62 Italy
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 64 Spain
  • Fig. 65 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 66 Denmark
  • Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 68 Sweden
  • Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 70 Norway
  • Fig. 71 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 72 Asia Pacific
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 74 China
  • Fig. 75 China market estimates and forecasts, 2018 - 2030
  • Fig. 76 Japan
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 78 India
  • Fig. 79 India market estimates and forecasts, 2018 - 2030
  • Fig. 80 Thailand
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Korea
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America
  • Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 88 Brazil
  • Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 90 Mexico
  • Fig. 91 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 92 Argentina
  • Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 94 Middle East and Africa
  • Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 96 South Africa
  • Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 100 UAE
  • Fig. 101 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 102 Kuwait
  • Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 104 Market share of key market players- Contrast enhanced ultrasound market